An approach for identifiability of population pharmacokinetic- pharmacodynamic models

CPT: Pharmacometrics and Systems Pharmacology

Volumn 2, Issue 6, 2013, Pages

  Shivva, V ^a   Korell, J ^a,b   Tucker, I G ^a   Duffull, S B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IVABRADINE;

ARTICLE; BIOAVAILABILITY; CLINICAL PHARMACOLOGY; CLINICAL STUDY; DRUG STRUCTURE; MATHEMATICAL MODEL; METABOLITE; PHARMACOKINETIC PHARMACODYNAMIC MODEL; POPULATION MODEL; PRIORITY JOURNAL; STUDY DESIGN; SYSTEMIC CIRCULATION; SYSTEMS BIOLOGY;

EID: 84881173325     PISSN: None     EISSN: 21638306     Source Type: Journal    
DOI: 10.1038/psp.2013.25     Document Type: Article

References (35)

1. Haefner, J.W. Modeling Biological Systems: Principles and Applications (Springer, New York, 2005).
2. Cobelli, C., Federspil, G., Pacini, G., Salvan, A. & Scandellari, C. An integrated mathematical model of the dynamics of blood glucose and its hormonal control. Math. Biosci. 58, 27-60 (1982). (Pubitemid 12109807)
3. Adam, J.A. A simplified mathematical model of tumor growth. Math. Biosci. 81, 229-244 (1986). (Pubitemid 17172482)
4. Wajima, T., Isbister, G.K. & Duffull, S.B. A comprehensive model for the humoral coagulation network in humans. Clin. Pharmacol. Ther. 86, 290-298 (2009).
5. Gibaldi, M. & Perrier, D. Pharmacokinetics (M. Dekker, New York, 1975).
6. Evans, N.D., Godfrey, K.R., Chapman, M.J., Chappell, M.J., Aarons, L. & Duffull, S.B. An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine. J. Pharmacokinet. Pharmacodyn. 28, 93-105 (2001).
7. Bellman, R. & Åström, K.J. On structural identifiability. Math. Biosci. 7, 329-339 (1970).
8. Chappell, M.J., Godfrey, K.R. & Vajda, S. Global identifiability of the parameters of nonlinear systems with specified inputs: a comparison of methods. Math. Biosci. 102, 41-73 (1990).
9. Godfrey, K.R., Chapman, M.J. & Vajda, S. Identifiability and indistinguishability of nonlinear pharmacokinetic models. J. Pharmacokinet. Biopharm. 22, 229-251 (1994). (Pubitemid 24378181)
10. Godfrey, K.R., Jones, R.P. & Brown, R.F. Identifiable pharmacokinetic models: the role of extra inputs and measurements. J. Pharmacokinet. Biopharm. 8, 633-648 (1980). (Pubitemid 11097022)
11. Jacquez, J.A. Identifiability: the first step in parameter estimation. Fed. Proc. 46, 2477-2480 (1987).
12. Jacquez, J.A. & Perry, T. Parameter estimation: local identifiability of parameters. Am. J. Physiol. 258, E727-E736 (1990). (Pubitemid 20142357)
13. Cobelli, C. & DiStefano, J.J. 3rd. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am. J. Physiol. 239, R7-24 (1980).
14. Yates, J.W., Jones, R.D., Walker, M. & Cheung, S.Y. Structural identifiability and indistinguishability of compartmental models. Expert Opin. Drug Metab. Toxicol. 5, 295-302 (2009).
15. Bortz, D.M. & Nelson, P.W. Model selection and mixed-effects modeling of HIV infection dynamics. Bull. Math. Biol. 68, 2005-2025 (2006). (Pubitemid 44705857)
16. Duffull, S.B., Wright, D.F. & Winter, H.R. Interpreting population pharmacokineticpharmacodynamic analyses-A clinical viewpoint. Br. J. Clin. Pharmacol. 71, 807-814 (2011).
17. Knutsson, I.-S.N. & Aarons, L. Identifiability of random effects parameters in mixed effects models. In 12th Annual Scientific Meeting, Population Approach Group in Australia and New Zealand (Adelaide, Australia, 2010).
18. Guedj, J., Thiébaut, R. & Commenges, D. Practical identifiability of HIV dynamics models. Bull. Math. Biol. 69, 2493-2513 (2007). (Pubitemid 350030795)
19. Bonate, P.L. The Art of Modeling 1-60 (Springer US, Boston, MA, 2011).
20. Bellu, G., Saccomani, M.P., Audoly, S. & D'Angiò, L. DAISY: a new software tool to test global identifiability of biological and physiological systems. Comput. Methods Programs Biomed. 88, 52-61 (2007). (Pubitemid 47331951)
21. Chis, O., Banga, J.R. & Balsa-Canto, E. GenSSI: a software toolbox for structural identifiability analysis of biological models. Bioinformatics 27, 2610-2611 (2011).
22. Mentré, F., Mallet, A. & Baccar, D. Optimal design in random-effects regression models. Biometrika 84, 429-442 (1997).
23. Fedorov, V.V. & Leonov, S.L. Optimal design of dose response experiments: a modeloriented approach. Drug. Inf. J. 35, 1373-1383 (2001). (Pubitemid 34563430)
24. Retout, S. & Mentré, F. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics. J. Biopharm. Stat. 13, 209-227 (2003). (Pubitemid 36523158)
25. Cramer, H. Mathematical Methods of Statistics (Princeton University Press, Princeton, USA, 1946).
26. Rao, C.R. Information and the accuracy attainable in the estimation of statistical parameters. Bull. Calcutta Math. Soc. 37, 81-91 (1945).
27. Bazzoli, C., Retout, S. & Mentré, F. Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0. Comput. Methods Programs Biomed. 98, 55-65 (2010).
28. Nyberg, J., Ueckert, S., Strömberg, E.A., Hennig, S., Karlsson, M.O. & Hooker, A.C. PopED: an extended, parallelized, nonlinear mixed effects models optimal design tool. Comput. Methods Programs Biomed. 108, 789-805 (2012).
29. Gueorguieva, I., Ogungbenro, K., Graham, G., Glatt, S. & Aarons, L. A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models. Comput. Methods Programs Biomed. 86, 51-61 (2007). (Pubitemid 46394511)
30. Bateman, H. Solution of a system of differential equations occurring in the theory of radioactive transformations. Proc. Camb. Philol. Soc. 15, 423-427 (1910).
31. Garrett, E.R. The Bateman function revisited: a critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination. J. Pharmacokinet. Biopharm. 22, 103-128 (1994). (Pubitemid 24288136)
32. Dost, F.H. Grundlagen der Pharmakokinetik. G. Thieme, Stuttgart: 2. Gufl 2, 38-47 (1968).
33. The MathWorks Inc. Getting Started with MATLAB®, Technical Computing Manual. (The MathWorks Inc., MA, USA, 2006).
34. Duffull, S.B., Denman, N., Kimko, H. & Eccleston, J. Population OPTimal design. In POPT-Installation and User Guide. (Duffull, S.B., School of Pharmacy, University of Otago, Dunedin, New Zealand, 2012).
35. Duffull, S.B., Chabaud, S., Nony, P., Laveille, C., Girard, P. & Aarons, L. A pharmacokinetic simulation model for ivabradine in healthy volunteers. Eur. J. Pharm. Sci. 10, 285-294 (2000). (Pubitemid 30317464)